ACADIA Pharmaceuticals (ACAD) Revenue
ACADIA Pharmaceuticals Revenue
ACADIA Pharmaceuticals had a revenue of 307.96M in the quarter ending Jun 30, 2026, with 14.88%. This bring the company's revenue in the last twelve months to 1.14B, Increased 3.96%. In the fiscal year ending Dec 31, 2025, ACADIA Pharmaceuticals had annual revenue of 1.07B with 11.87% growth.
- Revenue (ttm)
- 1.14B
- Revenue Growth
- 1.71%
- P/S Ratio
- 62.22
- Revenue/Employee
- MXN 1,344,423
- Employees
- 797
- Market Cap
- MXN 66.67B
Revenue Chart
ACADIA Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.07B | 113.71M | 11.87% |
| Dec 31, 2024 | 957.80M | 231.36M | 31.85% |
| Dec 31, 2023 | 726.44M | 209.20M | 40.45% |
| Dec 31, 2022 | 517.24M | 33.09M | 6.83% |
| Dec 31, 2021 | 484.14M | 42.39M | 9.60% |
| Dec 31, 2020 | 441.75M | 102.68M | 30.28% |
| Dec 31, 2019 | 339.08M | 115.27M | 51.50% |
| Dec 31, 2018 | 223.81M | 98.91M | 79.19% |
| Dec 31, 2017 | 124.90M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.